177 related articles for article (PubMed ID: 31171744)
1. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.
Varshosaz J; Dayani L; Chegini SP; Minaiyan M
IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744
[TBL] [Abstract][Full Text] [Related]
2. Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride.
Varshosaz J; Minaiyan M; Dayyani L
Eur J Pharm Sci; 2018 Jan; 112():195-206. PubMed ID: 29196024
[TBL] [Abstract][Full Text] [Related]
3. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
[TBL] [Abstract][Full Text] [Related]
5. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
[TBL] [Abstract][Full Text] [Related]
6. Enhanced solubility, oral bioavailability and anti-osteoporotic effects of raloxifene HCl in ovariectomized rats by Igepal CO-890 nanomicelles.
Varshosaz J; Ziaei V; Minaiyan M; Jahanian-Najafabadi A; Sayed-Tabatabaei L
Pharm Dev Technol; 2019 Feb; 24(2):133-144. PubMed ID: 29338533
[TBL] [Abstract][Full Text] [Related]
7. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
8. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
9. Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In Vitro.
Niu X; Wang X; Niu B; Li G; Yang X; Wang Y; Li G
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799909
[TBL] [Abstract][Full Text] [Related]
10. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.
Shah P; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575
[TBL] [Abstract][Full Text] [Related]
11. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
[TBL] [Abstract][Full Text] [Related]
13. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design:
Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA
Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.
Kushwaha AK; Vuddanda PR; Karunanidhi P; Singh SK; Singh S
Biomed Res Int; 2013; 2013():584549. PubMed ID: 24228255
[TBL] [Abstract][Full Text] [Related]
15. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
16. Morphological and Structural Properties of Amino-Functionalized Fumed Nanosilica and Its Comparison with Nanoparticles Obtained by Modified Stöber Method.
Ruiz-Cañas MC; Corredor LM; Quintero HI; Manrique E; Romero Bohórquez AR
Molecules; 2020 Jun; 25(12):. PubMed ID: 32580500
[TBL] [Abstract][Full Text] [Related]
17. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
Li Z; Zhang Y; Zhang K; Wu Z; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
[TBL] [Abstract][Full Text] [Related]
18. A matrix dispersion based on phospholipid complex system: preparation, lymphatic transport, and pharmacokinetics.
Li H; Lu S; Luo M; Li X; Liu S; Zhang T
Drug Dev Ind Pharm; 2020 Apr; 46(4):557-565. PubMed ID: 32126844
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension.
Li W; Yang Y; Tian Y; Xu X; Chen Y; Mu L; Zhang Y; Fang L
Int J Pharm; 2011 Apr; 408(1-2):157-62. PubMed ID: 21295124
[TBL] [Abstract][Full Text] [Related]
20. Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique.
Tran TH; Poudel BK; Marasini N; Woo JS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2013 Jan; 36(1):86-93. PubMed ID: 23325488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
